back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-07 15:53 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,227,104
+281,200 vol $7.92 each |
5,140,591 | |
| Filed 2025-03-07 15:52 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$666,056
+83,257 vol $8.00 each |
4,859,391 | |
| Filed 2025-03-07 15:51 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$454,981
+56,240 vol $8.09 each |
4,776,134 | |
| Filed 2025-03-07 15:51 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,587,502
+197,943 vol $8.02 each |
4,719,894 | |
| Filed 2025-03-07 15:50 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$451,460
+56,645 vol $7.97 each |
4,521,951 | |
| Filed 2025-03-07 15:49 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,762,756
+224,555 vol $7.85 each |
4,465,306 | |
| Filed 2025-03-07 15:48 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,732,896
+218,800 vol $7.92 each |
4,388,909 | |
| Filed 2025-03-07 15:48 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518,248
+64,781 vol $8.00 each |
4,170,109 | |
| Filed 2025-03-07 15:47 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$354,018
+43,760 vol $8.09 each |
4,105,328 | |
| Filed 2025-03-07 15:46 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,235,232
+154,019 vol $8.02 each |
4,061,568 | |
| Filed 2025-03-07 15:46 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$351,277
+44,075 vol $7.97 each |
3,907,549 | |
| Filed 2025-03-07 15:45 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,371,591
+174,725 vol $7.85 each |
3,863,474 | |
| Filed 2025-03-07 15:43 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
97 - Other
|
+3,688,749 vol |
3,688,749 | |
| Filed 2025-03-07 15:42 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-07 15:41 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
97 - Other
|
-3,688,749 vol |
4,240,751 | |
| Filed 2024-12-10 16:57 Tx date 2024-12-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,545,000
+500,000 vol $9.09 each |
7,929,500 | |
| Filed 2024-12-10 16:55 Tx date 2024-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,604,000
+400,000 vol $9.01 each |
7,429,500 | |
| Filed 2024-12-10 16:55 Tx date 2024-12-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,673,000
+300,000 vol $8.91 each |
7,029,500 | |
| Filed 2024-10-23 12:07 Tx date 2024-10-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Options
52 - Expiration of options
|
$-180,000
-30,000 vol $6.00 each |
0 | |
| Filed 2024-09-22 21:49 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2024-09-22 21:45 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2024-09-22 21:44 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,729,500 |